✦ LIBER ✦

Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations

✍ Scribed by Xueying Sharon Liang; Ruth M. Pfeiffer; William Wheeler; Dennis Maeder; Laurie Burdette; Meredith Yeager; Stephen Chanock; Margaret A. Tucker; Alisa M. Goldstein; Xiaohong R. Yang

Publisher: John Wiley and Sons
Year: 2011
Tongue: French
Weight: 846 KB
Volume: 130
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.26231

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Cutaneous malignant melanoma (CMM) is an etiologically heterogeneous disease with genetic, environmental (sun exposure) and host (pigmentation/nevi) factors and their interactions contributing to risk. Genetic variants in DNA repair genes may be particularly important since their altered function in response to sun exposure‐related DNA damage maybe related to risk for CMM. However, systematic evaluations of genetic variants in DNA repair genes are limited, particularly in high‐risk families. We comprehensively analyzed DNA repair gene polymorphisms and CMM risk in melanoma‐prone families with/without CDKN2A mutations. A total of 586 individuals (183 CMM) from 53 families (23 CDKN2A (+), 30 CDKN2A (−)) were genotyped for 2964 tagSNPs in 131 DNA repair genes. Conditional logistic regression, conditioning on families, was used to estimate trend p‐values, odds ratios and 95% confidence intervals for the association between CMM and each SNP separately, adjusted for age and sex. p‐Values for SNPs in the same gene were combined to yield gene specific p‐values. Two genes, POLN and PRKDC, were significantly associated with melanoma after Bonferroni correction for multiple testing (p = 0.0003 and 0.00035, respectively). DCLRE1B showed suggestive association (p = 0.0006). 28 ∼ 56% of genotyped SNPs in these genes had single SNP p < 0.05. The most significant SNPs in POLN and PRKDC had similar effects in CDKN2A (+) and CDKN2A (−) families. Our finding suggests that polymorphisms in DNA repair genes, POLN and PRKDC, were associated with increased melanoma risk in melanoma families with and without CDKN2A mutations.

📜 SIMILAR VOLUMES

Identification of modifier genes for cut

Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations

✍ Xiaohong Rose Yang; Ruth M. Pfeiffer; William Wheeler; Meredith Yeager; Stephen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 86 KB

## Abstract __CDKN2A__ is a major susceptibility gene for cutaneous malignant melanoma (CMM), but the variable penetrance and clinical manifestations among mutation carriers suggest the existence of modifier factors. The goal of this study was to identify modifier genes for CMM in CMM‐prone familie

Functional, structural, and genetic eval

Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients

✍ Caroline Kannengiesser; Sharon Brookes; Anna Gutierrez del Arroyo; Danielle Pham 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB 👁 1 views

Germline mutations of the CDKN2A gene are found in melanoma-prone families and individuals with multiple sporadic melanomas. The encoded protein, p16(INK4A), comprises four ankyrin-type repeats, and the mutations, most of which are missense and occur throughout the entire coding region, can disrupt

Germline mutation and large deletion ana

Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer

✍ Tadeusz Dębniak; Bohdan Górski; Rodney J. Scott; Cezary Cybulski; Krzysztof Mędr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 2 views

## Abstract The __CDKN2A/ARF__ genes have been associated with increased risk of malignant melanoma (MM) in families with multiple members affected by disease and in families characterized by the constellation of breast cancer and MM. The exact contribution of __CDKN2A/ARF__ to disease risk remains

Retention of the CDKN2A locus and low fr

Retention of the CDKN2A locus and low frequency of point mutations in primary and metastasic cutaneous malignant melanoma

✍ Anna Ruiz; Susana Puig; Michael Lynch; Teresa Castel; Xavier Estivill 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 124 KB 👁 2 views

CDKN2A has been found mutated in melanoma families which show linkage to chromosome 9p21. In contrast, a low mutation rate has been found in melanomas, suggesting that CDKN2A might not be the first target for mutation in the development of this type of tumour. To elucidate the role of the CDKN2A gen

Loss of expression of the p16INK4/CDKN2

Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage

✍ Lauri Talve; Ilari Sauroja; Yrjö Collan; Kari Punnonen; Tauno Ekfors 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 2 views

The G 1 /S checkpoint of the cell cycle is regulated by p16, p53 and RB tumor suppressor genes. Loss of expression of the p16 INK4 tumor suppressor protein, the product of the CDKN2 gene, has been associated with a wide variety of human malignancies. Mutations, loss of heterozygosity and deletions o

Affected members of melanoma-prone famil

Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF

✍ Ling Liu; Alisa M. Goldstein; Margaret A. Tucker; Herbert Brill; Nelleke A. Grui 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Mutations in the gene encoding the cell cycle inhibitor CDKN2A have been identified in some melanoma kindreds linked to 9p21. However, many such families show no evidence of mutations in the coding regions of CDKN2A. In this study, we examined whether two other potential tumor suppressors, CDKN2B an